Sahajanand Medical Technologies (SMT) announced significant new findings from four landmark clinical studies, namely TUXEDO ...

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes: Our Bureau, Mumbai Wednesday, October 29, 2025, 16:15 Hrs [IST] Sahajanand Medical Technologies (SMT), a medi ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

A bioadaptor implant that actively adapts to vessel physiology was linked to lower target lesion failure and target vessel ...

InterVene’s Recana, a mechanical thrombectomy catheter designed to address venous in-stent restenosis (ISR) and clear vessel obstructions, has received 510(k) clearance from the US Food and Drug ...

Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a ...

Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to control ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

In today's high-paced world, most of us spend sitting for long hours, either in the workplace, at the computer or during extensive travelling. Although sitting may appear to be a healthy activity, ...

Thrombosis is the underlying cause of 1 in 4 deaths worldwide each year. The campaign calls for crucial awareness and prevention. Observed annually on October 13, World Thrombosis Day underscores the ...

COULD ACTUALLY BE MUCH MORE ACCURATE. A MARY SALADNA IS IN THE NEWSROOM AND MARY THE RESULTS AREN’T GOOD. NO, THEY’RE NOT, BUT THE RESULTS ARE MORE REALISTIC AND MORE PROOF THAT BODY COMPOSITION ...